InsidersTradesSigma
Follow the ST凯利 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, ST凯利 has published 1 reports. Market capitalisation: €4bn. The latest transaction was reported on 21 January 2025 (Purchase). Among the most active insiders: 袁征. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
ST凯利 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XSHE. Se enfoca en el desarrollo y distribución de productos farmacéuticos.